Evan Loh
2019
In 2019, Evan Loh earned a total compensation of $2.3M as Chief Executive Officer at Paratek Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $364,375 |
|---|---|
| Salary | $520,000 |
| Stock Awards | $1,352,100 |
| Other | $22,521 |
| Total | $2,258,996 |
Loh received $1.4M in stock awards, accounting for 60% of the total pay in 2019.
Loh also received $364.4K in non-equity incentive plan, $520K in salary and $22.5K in other compensation.
Rankings
In 2019, Evan Loh's compensation ranked 5,314th out of 13,971 executives tracked by ExecPay. In other words, Loh earned more than 62.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,314 out of 13,971 | 62nd |
Division Manufacturing | 1,973 out of 5,695 | 65th |
Major group Chemicals And Allied Products | 697 out of 2,194 | 68th |
Industry group Drugs | 587 out of 1,880 | 69th |
Industry Pharmaceutical Preparations | 436 out of 1,392 | 69th |
Source: SEC filing on April 23, 2021.
Loh's colleagues
We found two more compensation records of executives who worked with Evan Loh at Paratek Pharmaceuticals in 2019.